PRION-1 scales analysis supports use of functional outcome measures in prion disease

Neurology

Volumn 77, Issue 18, 2011, Pages 1674-1683

  Mead, S ^a   Ranopa, M ^b   Gopalakrishnan, G S ^a   Thompson, A G B ^a   Rudge, P ^a   Wroe, S ^a   Kennedy, A ^a   Hudson, F ^b   MacKay, A ^c   Darbyshire, J H ^b   Collinge, J ^a   Walker, A S ^b  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b MRC CLINICAL TRIALS UNIT   (United Kingdom)

^c Argyll & Bute Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MEPACRINE;

ADULT; AGED; ARTICLE; COGNITION; COMPARATIVE STUDY; DISEASE COURSE; FUNCTIONAL ASSESSMENT; GLASGOW COMA SCALE; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRION DISEASE; PRIORITY JOURNAL; PSYCHIATRY; RATING SCALE; SCORING SYSTEM; SYMPTOMATOLOGY; VALIDITY;

EID: 82955243998     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182364890     Document Type: Article

References (15)

1. Stewart LA, Rydzewska LH, Keogh GF, Knight RS. Systematic review of therapeutic interventions in human prion disease. Neurology 2008;70:1272-1281. (Pubitemid 351520951)
2. Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 2001;24: 519-550. (Pubitemid 32695238)
3. Collinge J, Gorham M, Hudson F, et al. Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial. Lancet Neurol 2009; 2009:334-344.
4. Consumer workshop on clinical trials for CJD. Department of Health, Medical Research Council; 2002.
5. Bone I, Belton L, Walker AS, Darbyshire J. Intraventricular pentosan polysulphate in human prion disease: an observational study in the UK. Eur J Neurol 2008;15:458-464. (Pubitemid 351499197)
6. Tsuboi Y, Doh-ura K, Yamada T. Continuous intraventricular infusion of pentosan polysulfate: clinical trial against prion diseases. Neuropathology 2009;29:632-636.
7. Teasdale G, Jennett B. Assessment of coma and impaired consciousness: practical scale. Lancet 1974;2:81-84.
8. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
9. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimers disease. Am J Psychiatry 1984;141:1356-1364.
10. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962;10:799-812.
11. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414. (Pubitemid 23346995)
12. Schneider LS, Olin JT, Doody RS, et al. Validity and reliability of the Alzheimer's Disease cooperative study- clinical global impression of change. Alzheimer Dis Assoc Disord 1997;11:S22-S32.
13. Rankin J. Cerebral vascular accidents in patients over the age of 60. Scott Med J 1957;2:127-136.
14. Mahoney FI, Barthel D. Functional evaluation: the Barthel Index. Md State Medical Journal 1965;14:56-61.
15. Shuttleworth EC, Yates AJ, Paltan Ortiz JD. Creutzfeldt-Jakob disease presenting as progressive aphasia. J Natl Med Assoc 1985;77:649-650, 652, 656.